Back to BlackRock, Inc. BlackRock, Inc.

ESPRESPR
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ESPERION THERAPEUTICS INC NE

BlackRock, Inc. holds 22.1M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $69.9M as of 2026-Q2. The position was increased (+23.9% shares). ESPR represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$69.9M

Current Shares

22.1M

Total Value Change

+$38.6M

Total Shares Change

+7.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
22.1M
+23.9%
$69.9M0.0%$3.16
36
2026-Q1
Increased
17.9M
+1.0%
$48.9M0.0%$2.91
29
2025-Q4
Increased
17.7M
+19.2%
$65.4M0.0%$3.69
35
2025-Q3
Increased
14.8M
+0.8%
$39.3M0.0%$2.64
29
2025-Q2
Increased
14.7M
+1.5%
$14.5M0.0%$0.99
28
2025-Q1
Increased
14.5M
+1.8%
$20.9M0.0%$1.50
29
2024-Q4
New
14.2M
-
$31.3M0.0%$2.15
40

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used